Atrás
Rango del Día
$38.24
$40.15
Rango de 52 Semanas
$18.53
$56.05
Volumen
905,877
Promedio 50D / 200D
$43.18
/
$32.61
Cierre Anterior
$40.73
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -9.5 | 0.3 |
| P/B | 4.7 | 2.9 |
| ROE % | -50.7 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
Hold
$77.60
+95.2%
Low: $33.00
High: $97.00
EPS Futuro
-$5.26
Ingresos Est.
43 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$6.80
$2.26 – $16.10
|
1.4 B | 6 |
| FY2029 |
$4.25
$1.41 – $10.07
|
1.1 B | 6 |
| FY2028 |
$1.23
-$1.96 – $6.89
|
690 M | 8 |
Puntos Clave
Debt/Equity of 0.13 — conservative balance sheet
Negative free cash flow of -241.73M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-50.71%
ROIC-34.70%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.13
Current Ratio13.64
Interest Coverage-41.89
Valoración
P/E Ratio
-9.47
P/B Ratio4.69
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -299.62M |
| ROE | -50.71% | ROA | -40.78% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -241.73M |
| ROIC | -34.70% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.13 | Current Ratio | 13.64 |
| Interest Coverage | -41.89 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.47 | P/B Ratio | 4.69 |
| P/S Ratio | N/A | PEG Ratio | -0.16 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.84B | Enterprise Value | 2.56B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -299.62M | -152.15M | -95.99M | -89.06M | -32.61M |
| EPS (Diluted) | -4.66 | -2.75 | -2.25 | -3.35 | -2.43 |
| Gross Profit | -468,000.0 | 0.0 | 0.0 | 846,000.0 | 0.0 |
| Operating Income | -315.47M | -167.17M | -102.01M | -90.90M | -34.40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 734.73M | 655.68M | 175.55M | 131.44M | 83.75M |
| Total Liabilities | 130.21M | 78.53M | 73.86M | 54.53M | 14.16M |
| Shareholders' Equity | 604.52M | 577.16M | 101.69M | 76.91M | 69.59M |
| Total Debt | 77.31M | 54.64M | 53.71M | 31.29M | 4.92M |
| Cash & Equivalents | 354.73M | 92.65M | 45.68M | 43.46M | 79.67M |
| Current Assets | 728.88M | 651.22M | 172.02M | 125.70M | 82.54M |
| Current Liabilities | 53.46M | 25.37M | 22.30M | 25.60M | 7.69M |